Nektar announces new collaborations for registrational study of bempegaldesleukin in SCCHN Feb. 18, 2021
IMU-838 shows some evidence of clinical activity in CALVID-1 study in moderate COVID-19 Feb. 18, 2021
New HSP90-CDC37 protein-protein interaction inhibitors with antitumor in vitro and in vivo efficacy Feb. 18, 2021
A regulator of ER proteostasis shows promising antiviral activity against dengue and Zika viruses Feb. 18, 2021
Pfizer begins pivotal phase II study of elranatamab in relapsed or refractory multiple myeloma Feb. 17, 2021
RSS